small-volume parenteral preparations
TRANSCRIPT
Topics2
Chapter 9
Small-Volume Parenteral
Preparations
2012 Paradigm Publishing
Topics3
Learning Objectives
Recognize the origins of small-volume parenteral preparations—in particular, antibiotics.
Understand the USP Chapter <797> procedures that must be performed prior to sterile compounding procedures.
Identify the critical sites of various small-volume parenteral preparation supply items, and describe compounding situations in which certain supply items should be used.
Discover the USP Chapter <797> procedures that must be performed during small-volume parenteral preparation.
Demonstrate effective technique in the preparation of two small-volume compounded sterile preparations.
2012 Paradigm Publishing
Topics4
Topics
Learning Objectives
Introduction
IVPBs
Compounding of IVPBs
Administration of IVPBs
Potential Complications of Parenteral Therapy
USP Chapter <797> Guidelines for SVPs
Understand the Resources and Supplies
Preview the Lab Procedure
Chapter Summary
2012 Paradigm Publishing
In Slide Show view, click the desired topic to the left to link directly to the related slide. To return to this slide at any point in the presentation, click the Topics button below.
Topics55
Introduction
Small-volume parenteral (SVP) preparations—known simply as SVPs—are sterile solutions that typically have a volume of 25 mL, 50 mL, 100 mL, 150 mL, or 250 mL
in general, these solutions are neutral, isotonic, and isosmotic
2012 Paradigm Publishing
Topics66
IVPBs
The majority of SVPs prepared by sterile compounding personnel are IV piggybacks, or IVPBs
an IVPB is comprised of a small volume of a base solution and a medication
the standard IV base solution may be a sterile fluid such as dextrose 5% in water (D5W), normal saline (NS), half normal saline (½ NS), or sterile water
2012 Paradigm Publishing
Topics77
IVPBs…/2
Unlike an LVP that is given for hydration or the continuous infusion of medication, an IVPB is used solely for the intermittent IV administration of medication according to a dosing schedule specified by a prescriber
this intermittent infusion is accomplished by piggybacking the SVP through the tubing containing a patient’s primary IV solution
2012 Paradigm Publishing
Topics88
IVPBs…/3
2012 Paradigm Publishing
A limited number of IVPBs are supplied as premixed, shelf-stable, or frozen products
other types are available in vial and bag systems
the majority of ordered IVPBs must be compounded by an IV technician
Topics99
Compounding of IVPBs
A prescriber typically indicates the medication name, dose, and dosing interval or schedule, without specifying the base solution or volume
2012 Paradigm Publishing
Topics1010
Compounding of IVPBs…/2
The pharmacist considers several factors when choosing the most appropriate IVPB base solution and volume, including:
the compatibility of the medication with the base solution
the length of time over which the IVPB is to be administered
the kidney function and hydration status of the patient recipient
the minimum or maximum concentration required for safe administration of the drug
2012 Paradigm Publishing
Topics1111
Compounding of IVPBs…/3
Antibiotic Preparations
Antibiotics are antimicrobial medicines used to treat a variety of infections caused by certain types of microorganisms, such as fungi, protozoa, or bacteria
not effective in the treatment of viruses
The terms antibiotic drugs and antibacterial drugs are sometimes used interchangeably
2012 Paradigm Publishing
Topics1212
Compounding of IVPBs…/4
Antibiotic Preparations…continued
Most bacterial microorganisms are said to be either gram-positive or gram-negative organisms
in essence, gram-positive bacteria have thicker cell walls than gram-negative bacteria
patients requiring IVPB antibiotic therapy often undergo blood testing (known as a culture and sensitivity test) to determine which pathogenic organism is causing the infection and—if the microorganism is a type of bacteria—whether the organism is gram-positive or gram-negative
2012 Paradigm Publishing
Topics1313
Administration of IVPBs
IVPBs are administered over a short period
Most IVPBs are administered by piggybacking them through a patient’s primary IV lineoccasionally, an IVPB medication is administered to a
patient who does not have a primary IV line
in this situation, the IVPB is administered through secondary IV tubing, directly into the patient’s vein, via a temporary injection port. This type of injection port—called a heparin lock, saline lock, or, simply, a lock—is attached to a flexible needle that is maintained in the patient’s vein
2012 Paradigm Publishing
Topics1414
Potential Complications of Parenteral Therapy
All patients receiving parenteral therapy should be monitored for the following complications:nosocomial infectionallergic reaction (including anaphylaxis)phlebitistissuingembolismextravasationcellulitisStevens-Johnson syndromenephrotoxicity
2012 Paradigm Publishing
Topics1515
Potential Complications of Parenteral Therapy…/2
For antibiotic SVPs, there is an increased likelihood for allergic reactions, including anaphylaxis; Stevens-Johnson syndrome; and nephrotoxicity
2012 Paradigm Publishing
Topics1616
Potential Complications of Parenteral Therapy…/3
Incompatibility Issues
In addition to these risks, IVPBs, due to their administration setup, have the potential for incompatibility issues
for example, if two incompatible medications are administered through the same IV tubing, a precipitatecould form, clogging the IV tubing and potentially causing injury to the patient
2012 Paradigm Publishing
Topics1717
Potential Complications of Parenteral Therapy…/4
Incompatibility Issues…continued
The primary IV tubing or the lock must be flushed after the IVPB medication has been administeredif the patient is receiving a primary IV solution, the flush is
performed by lowering the empty IVPB bag with secondary tubing attached to a height that allows gravity to force the primary IV solution to back up into the secondary tubing line
for patients without a primary IV solution, the lock is usually flushed with a small volume of either NS solution, or a heparinized saline solution
2012 Paradigm Publishing
Topics1818
Potential Complications of Parenteral Therapy…/5
Antibiotic-Resistant Bacteria
IV technicians should be aware of a growing health concern in the use of antibiotic therapy—the development of antibiotic-resistant bacteria
known as superbugs
the evolution of superbugs has been influenced by two factors: the widespread use of antimicrobial disinfectants and the overuse of antibiotics
2012 Paradigm Publishing
Topics1919
Potential Complications of Parenteral Therapy…/6
Antibiotic-Resistant Bacteria …continued
Antimicrobial Overuse
an antimicrobial is a substance or chemical compound capable of killing or inhibiting the growth of microorganisms
antimicrobial agents may be found in many hand soaps, cleansers, and surface disinfectants, as well as some medicines
the rise in the use of these products has helped to strengthen various microbes
2012 Paradigm Publishing
Topics2020
Potential Complications of Parenteral Therapy…/7
Antibiotic-Resistant Bacteria …continued
Antibiotic Overuse
often, prescribers yield to a patient’s demand for an antibiotic for an illness that may be viral, not bacterial
another source of antibiotic overuse comes from the use of antibiotics in the meat and dairy industries, whose policies allow for the administration of prophylactic antibiotic treatment to promote animal growth and to prevent and treat illness in livestock
2012 Paradigm Publishing
Topics2121
Potential Complications of Parenteral Therapy…/8
Superbugs as a Global Health Threat
Due to the widespread use of antimicrobials and antibiotics, superbugs such as methicillin-resistant Staphylococcus aureus (MRSA), carbapenem-resistant Klebsiella pneumoniae (CRKP), and New Delhi metallo-beta-lactamase (NDM-1) are on the rise and considered by many scientists to pose a serious threat to global health
2012 Paradigm Publishing
Topics2222
Potential Complications of Parenteral Therapy…/9
Superbugs as a Global Health Threat…continued
The World Health Organization (WHO) used World Health Day (April 7, 2011) to issue an urgent plea: The message on this World Health Day is loud and clear. The world is
on the brink of losing these miracle cures. The emergence and spread of drug-resistant pathogens has accelerated. More and more essential medicines are failing. The therapeutic arsenal is shrinking. The speed with which these drugs are being lost far outpaces the development of replacement drugs. In fact, the R&D pipeline for new antimicrobials has practically run dry. The implications are equally clear. In the absence of urgent corrective and protective actions, the world is heading towards a post-antibiotic era, in which many common infections will no longer have a cure and, once again, kill unabated.
2012 Paradigm Publishing
Topics23
Your Turn
2012 Paradigm Publishing
1) This is a substance or chemical compound capable of killing or inhibiting the growth of microorganisms.
a. microbe
b. antibiotic
c. antimicrobial
d. saline
2) These are considered by many scientists to pose a serious threat to global health.
a. colds
b. bacterial infections
c. superbugs
d. viruses
In Slide Show view, click here to see the answer to Question 1. Then click again to advance to Question 2.
In Slide Show view, click here to see the answer to Question 2.
Topics2424
USP Chapter <797> Guidelines for SVPs
During the preparatory and compounding procedures of SVPs, an IV technician must adhere to the overarching principles set forth in USP Chapter <797>
these guidelines are reinforced in each facility’s P&P manual as well
in accordance with these guidelines, sterile compounding personnel must pay strict attention to aseptic technique protocols both in the anteroom and clean room
2012 Paradigm Publishing
Topics2525
Understand the Resources and Supplies
Essential Supplies
Most sterile compounding procedures require the same essential supply items to be available for use in both the anteroom and the clean room
2012 Paradigm Publishing
Topics2626
Understand the Resources and Supplies…/2
Procedure-Specific Supplies
IVPB Supplies – Vials
most IVPB compounding procedures require an IV technician to reconstitute a powdered antibiotic within a vial
to do so, the technician draws up diluent from a separate vial and injects that fluid into the vial containing the powdered antibiotic
there are several methods that may be used to complete this procedure, including the use of the milking technique, a vented needle, or a repeater pump
2012 Paradigm Publishing
Topics2727
Understand the Resources and Supplies…/3
Procedure-Specific Supplies
IVPB Supplies – Vials…continued
because positive pressure was created within the vial when the diluent was injected, the milking technique can be used to withdraw the dissolved powder from the vial without injecting air
this method of reconstituting a powder within a vial is best used when preparing a single CSP in which the entire contents of a vial are injected into the IVPB to provide the desired dose
2012 Paradigm Publishing
Topics2828
Understand the Resources and Supplies…/4
Procedure-Specific Supplies
IVPB Supplies – Vented Needles
in addition to regular needles, some IVPB sterile compounding situations require the use of a vented needle
2012 Paradigm Publishing
Topics2929
Understand the Resources and Supplies…/5
Procedure-Specific Supplies
IVPB Supplies – Vented Needles…continued
a vented needle has a razor tip and is surrounded by a tiny aluminum needle sheath
this unique design allows the injection of the diluent into the vial while simultaneously venting air from the vial
this type of needle is used solely to reconstitute a powdered medication within a vial
2012 Paradigm Publishing
Topics3030
Understand the Resources and Supplies…/6
Procedure-Specific Supplies
IVPB Supplies – IVPB Base Solutions
an IVPB base solution bag is very similar in design and function to that of an LVP bag
the IVPB base solution bag is only available with a tail injection port
when using an IVPB bag, the needle should be inserted directly into the injection port without regard to the position of the needle bevel, and without creating any bend to the needle, as is done when inserting a needle into a vial
2012 Paradigm Publishing
Topics3131
Understand the Resources and Supplies…/7
Critical Sites of Essential Supplies and IVPB Supplies
Before beginning preparatory procedures in the anteroom or clean room, the IV technician must recall the critical sites of the supplies
After identifying the critical sites of all supply items, care must be taken not to taint the critical site of any supply item through touch contamination, shadowing, or incorrect placement of the item within the hood
2012 Paradigm Publishing
Topics3232
Preview the Lab Procedure
Anteroom Preparatory Procedures verifying the CSP label against the
medication order
performing correct pharmacy calculations to determine type, size, and number of supply items needed
gathering and cleaning of supplies
performing aseptic garbing and hand washing
donning a sterile gown
2012 Paradigm Publishing
Topics3333
Preview the Lab Procedure…/2
Clean Room Preparatory Procedures
cleansing hands with sterile, foamed 70% IPA
donning sterile gloves
cleaning the hood
Once the hood has been cleaned, you must transfer the clean supplies from the transport vehicle or clean countertop to certain areas of the hood
2012 Paradigm Publishing
Topics3434
Preview the Lab Procedure…/3
SVP Compounding Procedure, Scenario One: Reconstitution Using the Milking Technique
2012 Paradigm Publishing
Topics3535
Preview the Lab Procedure…/4
SVP Compounding Procedure, Scenario Two: Reconstitution Using a Vented Needle
2012 Paradigm Publishing
Topics36
Your Turn
2012 Paradigm Publishing
3) This technique can be used to withdraw the dissolved powder from a vial without injecting air.
a. shadowing
b. reconstitution
c. milking
d. filtering
4) This type of needle has a razor tip and is surrounded by a tiny aluminum needle sheath.
a. regular
b. filter
c. vented
d. beveled
In Slide Show view, click here to see the answer to Question 3. Then click again to advance to Question 4.
In Slide Show view, click here to see the answer to Question 4.